Jill Beyer

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori

James Versalovic, Dee Shortridge, K. Kibler et al. · Antimicrobial Agents and Chemotherapy · 1996 · 504 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

Dwight J. Hardy, Dena M. Hensey, Jill Beyer et al. · Antimicrobial Agents and Chemotherapy · 1988 · 302 citations

Life Sciences, Infectious Diseases, Microbiology +16

Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994-1995

Virginia D. Shortridge, Gary V. Doern, Angela B. Brueggemann et al. · Clinical Infectious Diseases · 1999 · 177 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori

Gregory G. Stone, Dee Shortridge, James Versalovic et al. · Antimicrobial Agents and Chemotherapy · 1997 · 163 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Teresa I. Ng, Preethi Krishnan, Warren M. Kati et al. · Antimicrobial Agents and Chemotherapy · 2017 · 139 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17